Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

Amgen Inc. (AMGN)

-NasdaqGS
163.58 Down 3.29(1.97%) Apr 17, 4:00PM EDT
|After Hours : 163.13 Down 0.45 (0.27%) Apr 17, 7:33PM EDT
Add to Portfolio
Prev Close:166.87
Open:165.10
Bid:163.20 x 100
Ask:164.36 x 100
1y Target Est:176.79
Beta:0.6
Next Earnings Date:21-Apr-15AMGN Earnings announcement
Day's Range:161.72 - 165.50
52wk Range:108.20 - 173.14
Volume:4,249,688
Avg Vol (3m):3,421,110
Market Cap:124.13B
P/E (ttm):24.41
EPS (ttm):6.70
Div & Yield:3.16 (2.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AMGNDown 1.97%124.13B
JNJDown 0.21%276.88B
NVSDown 0.82%245.76B
TEVAUp 2.24%55.29B

Key Statistics

Forward P/E (1 yr):15.62
P/S (ttm):6.31
Ex-Dividend Date:12-May-15

Analysts

Annual EPS Est (Dec-15) :9.31
Quarterly EPS Est (Mar-15) :2.10
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.61

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback